Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

Completed · Phase 2 · Has a placebo group

Conditions studied: Postherpetic Neuralgia, Pain

In brief

The primary objective of this study is to evaluate the analgesic efficacy of 2 dose levels of V116517 versus placebo.

Key facts

Study ID
NCT01688947
Run by
Purdue Pharma LP
People needed
105
Starts
2012-09-01
Expected to finish
2014-04-01
Last updated by the study team
2014-05-12

Who can join

Age: 21 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.